Utförlig referenslista till neurosomatiska sjukdomar
(2006-05-07)

Aastrup-Samuels H: Om elöverkänslighet. Elöverkänsligas Riksförbund, Stockholm 2005.

Abbott, N.J., Rönnbäck, L. & Hansson, E. Astrocyte-endothelial interactions at the blood-brain barrier. Nature Reviews Neuroscience 7, 41-53, 2006.

Ader R, Cohen N, Felten D: Psychoneuroimmunology. Lancet 345: 99-103, 1995.

Afari, N. & Buchwald, D. (2003). Chronic fatigue syndrome: a review. American Journal of Psychiatry 160, 221-236.

Arnetz BB: Model development and research vision for the future of multiple chemical sensitivity. Scand J Work Environ Health 25: 569-73,1999

Arnold LD, Hudson JI et al: Family study of fibromyalgia. Arthritis Rheum 2004, 50:944-52.

Arnold LD et al: Vulvodynia: Characteristics and Associations With Comorbidities and Quality of Life. Obstet Gynecol. 2006 Mar;107(3):617-624.

Asa PB et al: Antibodies to Squalene in Gulf War Syndrome. Exp.Mol.Pathol. 2000;68:55-64.

Assefi NP, Sherman KJ, Jacobsen C, Goldberg J, Smith WR, Buchwald D.: A randomized clinical trial of acupuncture compared with sham acupuncture in fibromyalgia. Ann Intern Med. 2005 Jul 5;143(1):10-9.

Bajaj P et al: Endometriosis is associated with central sensitization…. J Pain 2003, 4:372-380.

Baraniuk JN, Claw et al: A chronic fatigue syndrome - related proteome in human cerebrospinal fluid. BMC Neurology 2005, 5:22 doi:10.1186/1471-2377-5-22

Baron DF et al: Joint hypermobility is more common in children with chronic fatigue syndrome than in healthy controls. Journal: J Pediatr 2002 Sep;141(3):421-5.

Barsky AJ, Borus JF: Functional Somatic Syndromes. Ann Intern Med. 1999; 130: 910-21.

Bell IR. et al: JP-8 jet fuel exposure and divided attention test performance in 1991 Gulf War veterans. Journal: Aviat Space Environ Med. 2005 Dec;76(12):1136-44.

Bennett R: Emerging Concepts in the Neurobiology of Chronic Pain…Mayo Clin Proc 1999;74:385-398.

Bennett R: Fibromyalgia: Present to Future. Curr Pain & Headache Rep 2004, 8:379-84.

Bergqvist U, Hillert L, Birke E: Elöverkänslighet och hälsorisker av elektriska och magnetiska fält. Slutrapport från Rådet för arbetslivsforskning (Stencil) Nov. 2000.

Berlin M: Kvicksilver i tandfyllningsmaterial – miljömedicinsk riskanalys. I Amalgamfrågan. FRN 1998.

Blockmans D. et al: Does methylphenidate reduce the symptoms of chronic fatigue syndrome? Journal: Am J Med. 2006 Feb;119(2):167.

Brante T: Vetenskapliga kontroverser som problemområde. I Amalgamfrågan. FRN 1998.

Buchwald D et al: Markers of Inflammation and Immune Activation in Chronic Fatigue and CFS. J Rheumatol 1997; 24:2: 372-375.

Buchwald D, Garrity D: Comparison of Patients with CFS, FMS and MCS. Arch Intern Med. 154: 2049-53. 1994.

Capuron L, …Reeves WC: Cognitive dysfunction relates to subjective report of mental fatigue in patients with chronic fatigue syndrome. Neuropsychopharmacology Online publication: 10 November 2005

Cameron B:…Lloyd A: Prolonged illness after infectious mononucleosis is associated with altered immunity but not with increased viral load. J.Infectious Diseases, vol. 193 (2006), pp 664-671.

Carruthers et al: CFS guidelines, Journal of Chronic Fatigue Syndrome, Vol 11 No 1 2003.

Chapman Cr, Gavrin J: Suffering: the contributions of persistant pain. Lancet 1999; 353: 2233-57.

Coderre TJ et al: Contribution of central neuroplasticity. Pain 52: 259-85, 1993.

Cohen H et al: Abnormal Sympathovagal Balance in Men with FMS. J Rheumatol 2001; 28: 581-9.

Cotrina ML, Nedergaard M: ATP as a Messenger in Astrocyte-Neuronal Communication. Neuroscientist 6: 120-6, 2000.

Coull JT: Neural Correlates of Attention and Arousal. Progress in Neurobiol. Vol 55, pp 343-361, 1998.

Covacci A. Et al: Helicobacter pylori Virulence and Genetic Geography. Science, Vol 284, 1999, pp 1328-33.

Covey WC et al: Brain-derived TNF … persistant pain. Brain Research. 859 (2000) 113-122.

Crofford LJ: Pregabalin for the treatment of fibromyalgia syndrome: Results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2005;52(4):1264-73.

Crofford LJ: The relationship of fibromyalgia to neuropathic pain syndromes. J Rheum. Suppl. 2005;75:41-5

Cullberg J: Dynamisk psykiatri. Natur och Kultur, 1993.

Dalén P: Se upp för somatiseringsfällan! Läkartidn. 99:817-8, 2002

Demitrack MA, Crofford LJ: Evidence for... in FMS and CFS. Ann N Y Acad Sci 1998; 840: 684-97.

Desmeules JA et al: Neurophysiological evidence for a central sensitisation in patients with fibromyalgia. Arthritis Rheum 2003, 48:1420-29.

Dessein PH et al.: Neuroendocrine defiency-mediated …in FMS: a promising paradigm? Pain 86(2000) 213-5.

Elvin A, Siosteen AK, Nilsson A, Kosek E.: Decreased muscle blood flow in fibromyalgia patients during standardised muscle exercise: A contrast media enhanced colour doppler study. Eur J Pain. 2006 Feb;10(2):137-44.

Eisen SA. et al: Gulf War Veterans' Health: Medical Evaluation of a U.S. Cohort Gulf War Veterans' Health: Medical Evaluation of a U.S. Cohort. Ann Int Med, 2005, 142, ( 11), 881-890.

Eriksson O: Studies on Premenstrual Dysphoria. Dig. Compr. Summaries of Uppsala Dissertations from the Faculty of Medicine 42, 2005.

Evengård B, Komaroff AL: Kroniskt trötthetssyndrom finns. Läkartidn; 1999;96: 3166-9.

Evengård B. et al: Prevalence of chronic fatigue in the Swedish twin registry. Psychological medicine, 2005.

Falls WA, Davis M : Behavioral and Physiological Analysis of Fear Inhibition. In: Ibid.(Neurobiol. 1995), pp 177-202.

Fields RD, Stevens B: ATP: an extracellular signaling molecule between neurons and

Friedberg F, Jason LA: CFS and FMS. J Clin Psychol 67: 633-55. 2001.

Fukuda K. et al: Chronic Multisymtom….Gulf War. JAMA; 280, 981-8,1999.

Gamsa A: The role of psychological factors in chronic pain. Pain 1994; 57:17-29.

Giesecke T. et al: The relationship between depression, clinical pain, and experimental pain in a chronic pain cohort. Arthritis Rheum. 2005 May 5;52(5):1577-1584

Giovengo SL, Russell IJ, Larsson AA: Increased Concentrations of NGF in CSF..…J Rheumatol 1999;26:1564-9

Goldstein JA: Betrayal by the Brain. The Haworth Medical Press, NY, 1996.

Goldstein JA: Tuning the Brain. The Haworth Medical Press, NY, 2004.

Graveling RA.et al: A review of MCS. Occup Environ Med 1999;56: 73-85

Guiou M et al: Cortical spreading depression produces long-term disruption of activity-related changes in cerebral blood volume and neurovascular coupling. J Biomed Opt 2005, 10:11004.

Guez M: Chronic neck pain. An epid, psych., SPECT-study with emphasis on whiplash-associated disorders. Dissertation, Umeå Univ, 2006.

Gur A. et al: Regional blood flow and cytokines in young females with fibromyalgia. Clin. and Exp. Rheumatolgy. 2002; 20: 753-760.

Haley RW et al: Effect of Basal Ganglia Injury…in GWS. Arch Neurol. 2000;57:1280-5.

Hansson E el al: Astrocyte and glutamate … Neurochemistry International 37(2000)

Hansson E., Rönnbäck L. 2004: Altered Neuronal-Glial Signaling in Glutamatergic Transmission as a Unifying Mechanism in Chronic Pain and Mental Fatigue. Neurochem Res. 29, 5: 989-96.

Hansson E., Rönnbäck L.: Glial neuronal signaling in the central nervous system. FASEB J. 17, 341-348, 2003.

Hansson E., Zügner R.: Kan kronisk smärta och smärtspridning induceras via gliala mekanismer? Läkartidn. (102) 47: 3552-8, 2005.

Harris AJ: Cortical origin of pathological Pain. Lancet 1999;354:1464-6.

Hechmann I et al: Comparison of Viral Antibodies---FMS. J Rheumatol 2001;28: 601-3.

Henriksson KG et al: Fibromyalgi och kronisk muskelvärk. Astra Läkemedel 2000.

Herlofson J: Psykiatrisk Diagnostik. I Psykiatri 91. Pilgrim Press, 1991.

Hermann GE, Holmes GM, Rogers RC.: TNF(alpha) modulation of visceral and spinal sensory processing. Curr Pharm Des. 2005;11(11):1391-409

Hillert L: Doften nyckelbegrepp för kemikalieöverkänsliga. Intervju. Kem. Tidskrift 4, 1999;

Hjalt C-Å et al: Helicobacter pylori illustrerar hur ett paradigmskifte slår igenom. Läkartidn. Vol 96, 1999, 3177-9.

Holmin LR: Alfred Nobel – Could He Have Had Fibromyalgia? JCR 1996, 2;5:251-6.

Horwitz BH et al: Neural modeling, functional brain imaging, and cognition. Trends in Cog. Sci. Vol 3, No 3, 1999, pp 91-98.

Hvenegaard V: Chronic fatigue syndrome, an acknowledged neurologic diagnosis [Danish]. Ugeskr Laeger. 2005 Feb 14;167(7):784-5

Hyland HJ: Physics and biology of mobile telephony. Lancet , 2000;356:1833-6

Ignatowski et al: Brain-derived TNF mediates neuropathic pain. Brain Research 841 (1999) 70-7.

Ismail K. et al: Is there a Gulf War syndrome. Lancet;353, 1999, 179-82.

Janal MN et al: Sub-typing CFS patients on the basis of 'minor' symptoms. Journal: Biol Psychol. 2006 Feb 9

Janca A: Rethinking somatoform disorders. Journal: Current Opinion in Psychiatry. 18(1):65-71, January 2005.

Ji RR: Mitogen-activated protein kinases as potential targets for pain killers. Curr Opin Investig Drugs 2004, 5:71-5.

Johansson G et al: Cerebral dysfunction in FMS. Acta Psychiatr. Scand 1995; 91:86-94.

Johansson O: ”Kunskapsläget avseende elöverkänslighet ”. Ett diskussionsbidrag till Workshop 2 den 8:e feb. 1999, på Rådet för Arbetslivsforskning. (Stencil)

Johansson O: Några tankar kring elöverkänslighet och bildskärmsskada. Rapport nr 1, Information från Enheten för Experimentell Dermatologi,KI,1996.

Johnson SK et al: Assessing Somatization Disorder in the Chronic Fatigue Syndrome. Psychosom. Med. 58:50-57, 1996.

Kato K, Sullivan PF, Evengard B, Pedersen NL.: Importance of genetic influences on chronic widespread pain. Arthritis Rheum. 2006 Apr 27;54(5):1682-1686

Keefe FJ, Rumble ME, Scipio CD, et al. Psychological aspects of persistent pain: current state of the science. J Pain 2004; 5:195-211.

Kennedy G. et al: Increased neutrophil apoptosis in chronic fatigue syndrome. J Clin Path. 57:891-893, 2004.

Kennedy G. et al: Oxidative stress levels are raised in chronic fatigue syndrome and are associated with clinical symptoms. Free Radic Biol Med. 2005 Sep 1;39(5):584-9.

Kilburn KH: Symptoms, Syndrome, and Semantics: MCS and CFS. Arch Env Health; 48, 368-9, 1993.

Komaroff AL: The Biology of Chronic Fatigue Syndrome. Am J Med. 2000; 108:169-171.

Komaroff AL: Unexplained Suffering in the Aftermath of War. Annals of Internal Medicine, 2005, Volume 142 Issue 11, Pages 938-939.

Krystal JH et al: Toward a Cognitive Neuroscience .... In: Neurobiological and Clinical Consequences of Stress: From Normal Adaptation to PTSD. Ed: Friedman MJ, Charney DS, Deutch AY. Lippincott-Raven Publishers, Philadelphia 1995 pp 239-69.

Kröner-Herwig B: Fibromyalgie und die Pforten der Warnehmung. Z Rheumatol 56: 319-321, 1997.

Kwan CL et al: Abnormal forebrain activity in functional bowel disorder patients with chronic pain. Neurology. 2005 Oct 25;65(8):1268-77.

Lange G et al: Brain MRI abnormalities in a subset of patients with CFS. J Neurol Sciences 171(1999) 3-7.

Lange G. et al: Objective evidence of cognitive complaints in Chronic Fatigue Syndrome: A BOLD fMRI study of verbal working memory. Neuroimage. 2005 Jun 1;26(2):513-24.

Larson AA et al.: Changes in the concentrations of amino acids in the CSF …with pain in patients with FMS. Pain 87 (2000) 201-211.

Lacour M. et al: Multiple chemical sensitivity syndrome (MCS)--suggestions for an extension of the U.S. MCS-case definition. Int J Hyg Environ Health, 2005; 208(3): 141-51.

Leavitt F, Katz RS: Distraction as a key determinant of impaired memory in patients with FMS. J Rheumatol. 2006 Jan;33(1):127-32.

Lembo T et al.: IBS patients show altered sensitivity to exogenous opioids. Pain 87 (2000) 137-47.

Lidbeck J: Centralt störd smärtmodulering förklaring till långvarig smärta. Läkartidn.; 96; 2843-51, 1999.

Lidbeck J: Somatisering – uttryck för en förlegad sjukdomssyn. Läkartidn.; 99; 1505-6, 2002.

Lindqvist G, Malmgren H: Organic Mental Disorders as Hypothetical Pathogenic Processes. Acta Psychiatr Scand 1993: 88: Suppl 373:5-17.

Lipowski ZJ: Somatization: The Concept and Its Clinical Application. Am J Psychiatry 145:11: 1358-68, 1988.

Liu H et al: NMDA-receptor regulation of substance P ... Nature 1997;386:721-4.

Loeser JD, Meizack R: Pain: an overview. Lancet 1999; 353: 1607-9.

Lorentz J et al: Middle and long latency somatosensory … in FMS.

Lundin A: Soamtisering. Astra Läkemedel, Södertälje 1999.

Lundin A: Somatisering – en utmaning för sjukvården. Läkartidn.;99; 1239-40, 2002.

Luthra A, Wessely S. Unloading the trunk: neurasthenia. CFS and race Soc Sci Med 2004; 58:2363-2369.

Lutenbacher S, Krieg J-C: Pain Perception in Psychiatric Disorders. A Review of the Literature. J psychiat. Res. Vol 28. No 2, 109-122, 1994.

Maes M et al: Lower serum zinc in Chronic Fatigue Syndrome (CFS): Relationships to immune dysfunctions and relevance for the oxidative stress status in CFS. Journal: J Affect Disord. 2005 Dec 7;

Maibach et al: MCS in CFS. J All Clin Immunol; 107, nr 2, s27-7, 2001.

Maslach C: Utbränd. Natur och Kultur 1985.

Mayer EA: Emerging Disease Model for Functional Gastrointestinal Disorders. Am J Med. 107(5A):15S-18S, 1999.

Mayou R. et al: Somatoform Disorders: Time for a New Approach in DSM-V. Am Journal Psych. 162:847-855, 2005.

McGinn C: Freud Under Analysis. N Y Review of Books, Vol XLVI, 17: 20-4, 1999.

McLean SA, Williams DA, Clauw DJ.: Fibromyalgia after motor vehicle collision: evidence and implications. Traffic Inj Prev. 2005 Jun;6(2):97-104.

McWhinney IR et al: Rethinking Somatization. Ann Intern Med. 1997;126:747-50.

Merskey H: Beware somatization. Eur J Pain: 4:3-4, 2000

Michelson D et al: Mediation of the Stress Response by the HPA-Axis. In: Ibid.(Neurobiol. 1995), pp 225-38.

Monmaney T: Marshalls hunch. The New Yorker, Sept 20: 64-72, 1993.

Monti-Bloch L. et al: The Human Vomeronasal System. Psychneuroendocrin.19, 1994, 673-686.

Montoya Pet al: Abnormal affective modulation of somatosensory brain processing among patients with fibromyalgia. Psychosom Med. 2005 Nov-Dec;67(6):957-63.

Montoya P et al: Altered processing of pain-related information in patients with fibromyalgia. Eur J Pain. 2005 Jun;9(3):293-303.

Mountz JM, Bradley LA, Alarcón GS: Abnormal Functional Activity of the CNS in FMS. Am J Med Sci 1998;38:385-396

Neumann h….Buskila D: Prevalence of post-traumatic stress disorder in fibromyalgia patients: Overlapping syndromes or post-traumatic fibromyalgia syndrome? Semin Arthritis Rheum 2002 Aug;32(1):38-50.

Nicholson GL et al: Diagnos and Treatment of Systemic Mycoplasma Infections in Gulf War. Abstract. 2:d World Congress on CFS, Brussel Sept 1999, pp 8-9.

Nijs J…. De Meirleir K: Employment status in chronic fatigue syndrome. A cross-sectional study examining the value of exercise testing and self-reported measures for the assessment of employment status. Journal: Clin Rehabil. 2005 Dec;19(8):895-9.

Obata K, Noguchi K: MAPK activation in nociceptive neurons and pain hypersensitivity. Life Sci 2004, 74:2643-53.

Ofluoglu D. et al: Hypermobility in women with fibromyalgia syndrome. Clin Rheumatol. 2005 Oct 16:1-3.

Olgart L: Genombrott inom smärtforskningen. Läkartidn, 94: 4461-6, 1997.

Olin R: Fibromyalgi. Ett neuroimmunoendokrinologiskt syndrom? Läkartidn.; 92: 755-63, 1995

Olin R, Schenkmanis U: Fibromyalgi. Sv. Radios förlag. 1996.

Olin R: Fibromyalgi – ett reaktionssätt? Svensk Medicin 1996;5: 238-49.

Olin R, Lidbeck J: Fibromyalgi – förklaringarna skall sökas centralt, inte perifert. Läkartidn. 93: 2125-6, 1996.

Olin R, Klein R, Berg PA: A Randomised Double-Blind 16-Week Study of Ritanserin in FMS: Clinical Outcome and Analysis of Auto-antibodies to Serotonin, Gangliosides and Phospholipides. Clin Rheumatol (1998) 17:89-94.

Olin R, Paulander J, Axelsson P: FMS-, CFS- and TMS-Prevalences in a Swedish County (Värmland). A questionnaire and oral examination based study. Abstract. Second World Congress on CFS and related disorders. Brussels, Sept. 1999.

Olin R.: ”Nya diagnoser” – en förklaringsmodell till neurosomatiska sjukdomar. Nationella folkhälsokommittén, Regeringskansliet, Stockholm, 1999.

Olin R: Auditory hallucinations and the bicameral mind. The Lancet (1999) 354:166.

Olin R.: Trötthet & värk. Fibromyalgi och andra neurosomatiska sjukdomar. Rafael bokförlag, Karlstad, 2002. (Boken är slutsåld).

Pall ML: NMDA sensitization and stimulation by peroxynitrite, nitric oxide, and organic solvents as the mechanism of chemical sensitivity in multiple chemical sensitivity. The FASEB Journal. 2002;16:1407-1417.

Palm Ö et al: FMS …IBS; A Cross Sectional Population Survey. J Rheumatol 2001; 28: 590-4.

Pardaens K. et al:How relevant are exercise capacity measures for evaluating treatment effects in chronic fatigue syndrome? Results from a prospective, multidisciplinary outcome study. Clin Rehabil. 2006 Jan;20(1):56-66.

Persky A (red) et al: Stress och sjukdom. Alectra, Sthlm 2001.

Pillemer SR et al: The Neuroscience and Enocrinology of Fibromyalgia. Arthr. Rheum. Vol 40, 1997, pp 1928-39.

Ploghaus A et al: Dissociating Pain from its Anticipation in the Human Brain. Science Vol 284: 1979-81, 1999.

Post RM et al: Sensitization and Kindling. In: Ibid. (Neurobiol. 1995), pp 203-24.

Price DD, Staud R.: Neurobiology of fibromyalgia syndrome. J Rheum. Suppl. 2005;75:22-8.

Prins JB, van der Meer JWM, Bleijenberg: G: Chronic fatigue syndrome. The Lancet 2006; 367: 346-355.

Quintner JL, Cohen ML: Fibromyalgia falls foul of a fallacy. The Lancet 1999; 353: 1092-4.

Reeves WC. Et al: Chronic fatigue syndrome - a clinically empirical approach to its definition and study. BMC Med. 2005 Dec 15;3(1):19

Reid S et al: MCS and CFS in British Gulf War Veterans. Am J Epidemiol 2001; 153:604-9.

Reid S, Wessely S: Somatoform Disorders. Curr Opin Psych 12:163-8, 1999.

Riedel G: Function of metabotrofic glutamate receptors in learning and memory. TINS, 19: 219-224, 1996.

Rief W, Sharpe M: Somatoform disorders­­ - new approaches to classification, conceptualization, and treatment. J. Psychosom Res 56 (4):387-390, 2004.

Rosmond R, Björntorp P: Låg kortisolproduktion vid kronisk stress. Läkartidn.2000; 97:4120-4.

Russell IJ, Bennett RM, Michalek JE.and the Oxybate for FMS Study Group. Orally-administered Sodium oxybate relieves pain and improves sleep in patients with FMS. A randomised, double-blind, placebo-controlled, multi-center study. Abstract. ACR Annual Meeting in San Diego,2005.

Rutowsi MD, DeLeo JA 2002: The role of cytokines in the initiation and maintenance of chronic pain. Drug News Perspect. 15:626-32.

Rönnbeck L, Olsson T, Hansson E: Astrocyterna.. Läkartidningen 97;24:2956-61, 2000.

Rönnbäck L, Olsson T, Hansson E: Astrocyterna – hjärnans doldisar, delaktiga i neurastena symtom. Läkartidningen (97) 24:2956-61, 2000.

Rönnbäck L., Hansson E.: Cognitive impairment during recovery from whiplash injury – underlying mechanisms focusing on astroglial dysfunction in glutmatergic neurotransmission. J. Whiplash & Related Disorders 2, 17-29, 2003.

Rönnbäck L., Hansson E.: On the potential role of glutamate transport in mental fatigue. J Neuroinflammation 1:22, 2004.

Rönnbäck L. et al: "Trött i hjärnan"... Läkartidningen (vol. 14-15, s.1137-42, 2007). 

Salford L: Telefon öppnar hjärnan för risker. Intervju SvD 15/9 1999.

Salomon Y et al: Signaling Mechanisms Controlled by Melanocortins in Melanoma, Lacrimal, and Brain Astroglial Cells. Ann N Y Acad Sci, 680: 365-79, 1993.

Sayar k. et al: Venlafaxine treatment of fibromyalgia. Ann Pharmacother. 2003 Nov;37(11):1561-5.

SBU-rapport: Ont i ryggen – ont i nacken. Nr 145/1-2, 2000.

Schumacher HR: Patients with ”Gulf War Syndrome”. Editorial. J Rheumatol 1998 ; 25:11: 2059-61.

Smythe HA: Incarnations of fibromyalgia. J Rheumatol. 2005 Aug;32(8):1422-5.

Socialstyrelsen: Fibromyalgi. Stimulansbidrag 2000:03.

SoS Rapport 1994:4. Behandling av långvarig smärta.

Sumathipala A, Siribaddana SH, Bhugra D. Culture-bound syndromes: the story of dhat syndrome. Br J Psychiatry 2004; 184:200-209

Sparks PJ. Et al: MCS Sensitivity. JOM; 36, 718-730, 1994.

Sprott H., Bradley L. et al: (Om deficit i musklers mitokondrieantal vid fms). Ann Rheum Dis 63:245-51, 2004.

Sprott H. et al.: Increased DNA fragmentation and ultrastructural changes in fibromyalgic muscle fibers. Ann Rheum Dis 2004, 63:245–251.

Staud R: Evidence of involvement of central neural mechanisms in generating fibromyalgia pain. Curr Rheumatol Rep 2002, 4:299-305

Staud R. et al: Isometric exercise has opposite effects on central pain mechanisms in patients compared to normal controls. Pain. 2005 Sep 8;

Stejskal VDM: VDM et al: Metal-specific memory lymphocytes: biomarkers of sensitivity in man. Neuroendocrinology Letters. 1999.

Sternberg EM, Smith CC: Overview. Neuroimmunomodulation 3:323-4, 1996.

Stratz T, Müller W: The use of 5-HT3 …in FMS? Scand J Rheumatol 2000; Suppl 113: 66-71.

Sugiya E, Takato M, Noda Y: Neuronal and glial activity during spreading depression in cerebral cortex of cat. J Neurophysiol 1975, 38:822-841

Söderfeldt M: Burnout? Doktorsavhandling. Meddelanden från Socialhögskolan 1997:2. Lunds Universitet.

Söndergaard HP: Traumatisk stress. Läkartidningen.; 90, 796-800,1993

Takata M. et al: Reduced responsiveness is an essential feature of chronic fatigue syndrome: A fMRI study. BMC Neurology, Vol 6, Feb. 22, 2006.

Thorlin T: Delta-Opioid Receptors on Astrocytes. Thesis. Institute of Clinical Neuroscience, Göteborg University, 1998.

Thorpy DJ et al: Responses of the sympathetic nervous system…to interleukin-6. Arthr.Rheum, Vol 43,2000, 872-80.

Timothy R, Gerrity TR et al: Immunologic aspects of chronic fatigue syndrome. Neuroimmunomodulation 2004;11:351-357.

Treede R-D et al: The cortical representation of pain. Pain 1999, 79: 105-111.

Ullan et al: Control of Synapse Number by Glia. Science; 291:657-60, 2001.

Wade JB et al: Patterns of normal personality structure among chronic pain patients. Pain 1992; 48:37-43.

Van Cauter E et al: Insomnia and Sleep Health Expert Column. The Impact of Sleep Deprivation on Hormones and Metabolism. Medscape Neurology & Neurosurgery. 2005; 7 (1): .

Van Santen M.et al: A Randomized Clinical Trial Comparing Fitness and Biofeedback Training versus Basic Treatment in Patients with Fibromyalgia. J Rheumatol 2002;29:575-81

Van Wagoner NJ, Benveniste EN: Interleukin-6 expression and regulation in astrocytes. J. Neuroimmunol. 100(1999) 124-39.

Vasey FB, Seleznick MJ: Epidemiology versus Outcome. The Silicone Breast Implant Controversy. Editorial. J Rheumatol. 1999; 26:5: 1018-9.

Watkins LR et al: Immune activation: pain states. Pain 1995, 63: 289-302.

Watkins LR, Maier SF: Implications of immune-to-brain communications. PNAS, 96; 7710-3, 1999.

Watkins LR, Milligan ED, Maier SF: Glial activation: a driving force for pathological pain. Trends Neurosci 2001, 24:450-5.

Watkins LR, Maier SF: Beyond neurons: Evidence that immune and glial cells contribute to pathological pain states. Physiol. Rev. 82:981-1011, 2002.

Weinburger DR: A Connectionist Approach to the Prefrontal Cortex. J Neuropsych Vol 5, 3, 1993, pp 241-53.

Vercoulen J et al: Prognosis in chronic fatigue syndrome. J Neurol Neurosurg Psychiatry 1996; 60: 489-94.

Werle E et al: Antibodies Against Serotonin ... FMS. J Rheumatol 2001; 28: 595-600.

Wessely S: The Long Aftermath of the 1991 Gulf War. Ann Int Med, July 2004 | Volume 141 (2): 155-156.

Whistler T et al: Gene expression correlates of unexplained fatigue. Pharmacogenomics. Vol. 7, Nr 3, pp395-405, 2006

Williams DA, Mease PJ, McLean SA, Clauw DJ.: Efficacy of milnacipran in patients with fibromyalgia. J Rheumatol. 2005 Oct;32(10):1975-85.

Wilson R: Anti-Polymer Antibody Reactivity in a Subset of Patients with Fibromyalgia. J Rheumatol, 1999, 26: 402-7.

Winberg J: Smärta hos nyfödd styr smärtreaktionen i vuxenlivet. Läkartidn. 1998; 37: 3945-6.

Wolfe F: ”Silicone Related Symtoms”. J Rheumatol 1999;26:1172-5.

Wolfe F, Katz RS, Michaud K. Jaw Pain: Its Prevalence and Meaning in Patients with Rheumatoid Arthritis, Osteoarthritis and Fibromyalgia. J Rheumatol. 2005 Dec;32(12):2421-2428.

Yoshiuchi K. et al: Patients with chronic fatigue syndrome have reduced absolute cortical blood flow. Journal: Clin Physiol Funct Imaging. 2006 Mar;26(2):83-6.

Yunus MB: Psychological aspects of fibromyalgia syndrome. Baillière’s Clin Rheum. 8:811-36, 1994.

Yunus MB, Bennett RM …Olin.R. et al: Fibromyalgia Consensus Report. J Clin Rheumatol., 1997;3:324-7.

Yunus MB: Guest Editorial. Suffering, Science and Sabotage. J. Musculoskel. Pain, Vol. 12(2): 3-18, 2004.

Österberg K et al: Annoyance and performance.. three groups…chemical odors. Scand J Work Environ health, 200;30:486-96.

"Scientific Progress in Understanding Gulf War Veterans' Illnesses: Report and Recommendations" Research Advisory Committee on Gulf War Veterans' Illnesses, September, 2004"
http://www1.va.gov/rac-gwvi/docs/ReportandRecommendations_2004.pdf